Sources, Quality and Prices of Active Pharmaceutical Ingredients of Antiretroviral Drugs: Results of a 2012 WHO Survey

This document reports on a survey by WHO on the market for Active Pharmaceutical Ingredients (API) of antiretroviral (ARV) drugs, conducted in the first quarter of 2012. The information requested from the manufacturers included whether they produce ARV APIs, what is their API price, the regulatory status and pharmacopoeia standard of their products, their production capacity, storage conditions and whether they have an APIMF (API Master File) available or not. Thirteen manufacturers responded.

Planning & Budgeting, Pricing, Procurement, Quality Assurance, Selection

  • Sub-categories HIV/AIDS
  • Commodities Medicines
  • Latest update 2012
  • Version
  • Developed by WHO
  • When to use This document reports on a survey by WHO on the market for Active Pharmaceutical Ingredients (API) of antiretroviral (ARV) drugs, conducted in the first quarter of 2012. The information requested from the manufacturers included whether they produce ARV APIs, what is their API price, the regulatory status and pharmacopoeia standard of their products, their production capacity, storage conditions and whether they have an APIMF (API Master File) available or not. Thirteen manufacturers responded.
  • Languages English
  • Level of use Central
  • Form PDF file
  • Amount of training / TA required n/a
  • Inputs & outputs n/a
  • Cost none
  • Advantages n/a
  • Limitations WHO has made every effort to ensure the accuracy of the information presented, but the readers should realize that manufacturing and production Capacity are a highly dynamic area, and that data can therefore never be complete. The data and information contained herein are being provided as is.
  • Availability http://apps.who.int/iris/bitstream/10665/75172/1/9789241503778_eng.pdf
  • Remarks
  • Contact Contact AMDS, WHO. Email: amds@who.int
  • Submission date 2012-07-26 14:48:41